| Bioactivity | Urease-IN-11 (Compound 6e) is a competitive urease inhibitor (IC50)=10.41 µM). Urease-IN-11 can be used to study diseases such as urease-related gastritis and peptic ulcer[1]. |
| Target | Urease. |
| Name | Urease-IN-11 |
| CAS | 517906-12-6 |
| Formula | C21H15N5S |
| Molar Mass | 369.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ullah S, et al. Urease inhibitory potential of pyridine-containing triazolothiadiazole and triazolothiadiazine scaffolds for the treatment of ulceration and kidney stone: in vitro screening, kinetics mechanism, and in silico computational analysis. J Biomol Struct Dyn. 2023 Dec 28:1-10. |
Urease-IN-11
CAS: 517906-12-6 F: C21H15N5S W: 369.44
Urease-IN-11 (Compound 6e) is a competitive urease inhibitor (IC50)=10.41 µM). Urease-IN-11 can be used to study diseas
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.